Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (498)	3/10/1999 1:50:00 PM
From: DLJMT	Respond to of 4974

Does anyone know why ENZN has moved up from a plateau suddenly since yesterday on large volume and no news? (I'm not complaining since I've been long since in the two's, just wondering if I'm missing something.)

To: scaram(o)uche who wrote (498)	3/10/1999 1:55:00 PM
From: mike head	Read Replies (1) \| Respond to of 4974

They've been trying for a long time... Is this it? Broad Patent Issues for Paclitaxel Production by Microorganisms; Establishes Strong Proprietary Position DALLAS, March 10 /PRNewswire/ -- Cytoclonal Pharmaceutics Inc. (Nasdaq: CYPH - news, CYPH - news, CYPHZ - news) today announced the issuance of a broad patent (U.S. Patent # 5,861,302) for the production of paclitaxel, the active ingredient in Taxol(TM), by microorganisms isolated from the Yew Tree. Partial release!